Eshan A Narasipura

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 10

Top Topics

Top Venues

Biomaterials science

Bioconjugate chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Yutian Ma, Palas B Tiwade, Rachel VanKeulen-Miller, Eshan A Narasipura, Owen S Fenton
Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery. Nano letters 24 (20) (2024)
Yutian Ma, Palas B Tiwade, Rachel VanKeulen-Miller, Eshan A Narasipura, Owen S Fenton
Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery. Nano letters (2024)
Eshan A Narasipura, Owen S Fenton
Advances in non-viral mRNA delivery to the spleen. Biomaterials science 12 (12) (2024)
Yutian Ma, Palas B Tiwade, Rachel VanKeulen-Miller, Eshan A Narasipura, Owen S Fenton
Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery. Nano letters 24 (20) (2024)
Eshan A Narasipura, Owen S Fenton
Advances in non-viral mRNA delivery to the spleen. Biomaterials science 12 (12) (2024)
Eshan A Narasipura, Owen S Fenton
Advances in non-viral mRNA delivery to the spleen. Biomaterials science (2024)
Yutian Ma, Palas B Tiwade, Rachel VanKeulen-Miller, Eshan A Narasipura, Owen S Fenton
Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery. Nano letters 24 (20) (2024)
Eshan A Narasipura, Owen S Fenton
Advances in non-viral mRNA delivery to the spleen. Biomaterials science 12 (12) (2024)
Yutian Ma, Palas B Tiwade, Rachel VanKeulen-Miller, Eshan A Narasipura, Owen S Fenton
Polyphenolic Nanoparticle Platforms (PARCELs) for In Vitro and In Vivo mRNA Delivery. Nano letters 24 (20) (2024)
Eshan A Narasipura, Rachel VanKeulen-Miller, Yutian Ma, Owen S Fenton
Ongoing Clinical Trials of Nonviral siRNA Therapeutics. Bioconjugate chemistry (2023)